IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
INVO Fertility, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.60+0.04 (+7.78%)
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
INVO Fertility, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | % of revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fertility Clinic Services [Member] | $7.42M | $7.08M | $6.72M | $6.45M | – | – | – | – | – | – | – | – | 98.5% |
| INVOcell Device [Member] | $152.69K | $176.55K | $147.19K | $110.57K | – | – | – | – | – | – | – | – | 2.0% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | % of revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From External Customers [Member] | $7.53M | $7.22M | $6.84M | $6.53M | – | – | – | – | – | – | – | – | 100.0% |
| Clinic Revenue [Member] | $7.42M | $7.08M | $6.72M | $6.45M | $6.13M | $5.66M | $4.10M | $2.86M | $1.72M | $948.39K | $806.39K | $614.85K | 98.5% |
| Product [Member] | $113.69K | $137.55K | $120.19K | – | $101.72K | $113.58K | $146.44K | $158.00K | $197.07K | $229.00K | $201.24K | $207.34K | 1.5% |
| Inter Segment Revenue [Member] | $27.88K | $34.50K | $27.00K | $29.00K | – | – | – | – | – | – | – | – | 0.4% |
By region
From the segment and revenue-disaggregation notes of INVO Fertility's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.